112 related articles for article (PubMed ID: 32318056)
1. Mechanisms of FH Protection Against Neovascular AMD.
Borras C; Delaunay K; Slaoui Y; Abache T; Jorieux S; Naud MC; Sanharawi ME; Gelize E; Lassiaz P; An N; Kowalczuk L; Ayassami C; Moulin A; Behar-Cohen F; Mascarelli F; Dinet V
Front Immunol; 2020; 11():443. PubMed ID: 32318056
[TBL] [Abstract][Full Text] [Related]
2. Granzyme B Contributes to Choroidal Neovascularization and Age-Related Macular Degeneration Through Proteolysis of Thrombospondin-1.
Obasanmi G; Zeglinski MR; Hardie E; Wilhelm AC; Turner CT; Hiroyasu S; Boivin WA; Tian Y; Zhao H; To E; Cui JZ; Xi J; Yoo HS; Uppal M; Granville DJ; Matsubara JA
Lab Invest; 2023 Jun; 103(6):100123. PubMed ID: 36849037
[TBL] [Abstract][Full Text] [Related]
3. Natural immunoglobulin M-based delivery of a complement alternative pathway inhibitor in mouse models of retinal degeneration.
Annamalai B; Parsons N; Nicholson C; Joseph K; Coughlin B; Yang X; Jones BW; Tomlinson S; Rohrer B
Exp Eye Res; 2021 Jun; 207():108583. PubMed ID: 33878326
[TBL] [Abstract][Full Text] [Related]
4. Regulatable Complement Inhibition of the Alternative Pathway Mitigates Wet Age-Related Macular Degeneration Pathology in a Mouse Model.
Parsons NB; Annamalai B; Rohrer B
Transl Vis Sci Technol; 2023 Jul; 12(7):17. PubMed ID: 37462980
[TBL] [Abstract][Full Text] [Related]
5. The Noncanonical Role of Complement Factor H in Retinal Pigment Epithelium (RPE) Cells and Implications for Age-Related Macular Degeneration (AMD).
Armento A; Merle DA; Ueffing M
Adv Exp Med Biol; 2023; 1415():9-13. PubMed ID: 37440007
[TBL] [Abstract][Full Text] [Related]
6. The Binding of CD93 to Multimerin-2 Promotes Choroidal Neovascularization.
Tosi GM; Neri G; Barbera S; Mundo L; Parolini B; Lazzi S; Lugano R; Poletto E; Leoncini L; Pertile G; Mongiat M; Dimberg A; Galvagni F; Orlandini M
Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):30. PubMed ID: 32697305
[TBL] [Abstract][Full Text] [Related]
7. Targeting cell-type-specific, choroid-peripheral immune signaling to treat age-related macular degeneration.
Lin JB; Santeford A; Colasanti JJ; Lee Y; Shah AV; Wang TJ; Ruzycki PA; Apte RS
Cell Rep Med; 2024 Jan; 5(1):101353. PubMed ID: 38232696
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration.
Bora PS; Hu Z; Tezel TH; Sohn JH; Kang SG; Cruz JM; Bora NS; Garen A; Kaplan HJ
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2679-84. PubMed ID: 12589025
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 monooxygenase lipid metabolites are significant second messengers in the resolution of choroidal neovascularization.
Hasegawa E; Inafuku S; Mulki L; Okunuki Y; Yanai R; Smith KE; Kim CB; Klokman G; Bielenberg DR; Puli N; Falck JR; Husain D; Miller JW; Edin ML; Zeldin DC; Lee KSS; Hammock BD; Schunck WH; Connor KM
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):E7545-E7553. PubMed ID: 28827330
[TBL] [Abstract][Full Text] [Related]
10. Granzyme B degrades extracellular matrix and promotes inflammation and choroidal neovascularization.
Obasanmi G; Uppal M; Cui JZ; Xi J; Ju MJ; Song J; To E; Li S; Khan W; Cheng D; Zhu J; Irani L; Samad I; Zhu J; Yoo HS; Aubert A; Stoddard J; Neuringer M; Granville DJ; Matsubara JA
Angiogenesis; 2024 Mar; ():. PubMed ID: 38498232
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein-complement factor H axis as a biomarker of activity in early and intermediate age-related macular degeneration.
Giralt L; Figueras-Roca M; Eguileor BL; Romero B; Zarranz-Ventura J; Alforja S; Santiago F; Bolaños J; Lozano F; Dotti-Boada M; Sala-Puigdollers A; Dura P; Izquierdo-Serra J; Valero O; Adan A; Fonollosa A; Molins B
Front Immunol; 2024; 15():1330913. PubMed ID: 38633250
[TBL] [Abstract][Full Text] [Related]
12. Targeting complement components C3 and C5 for the retina: Key concepts and lingering questions.
Kim BJ; Mastellos DC; Li Y; Dunaief JL; Lambris JD
Prog Retin Eye Res; 2021 Jul; 83():100936. PubMed ID: 33321207
[TBL] [Abstract][Full Text] [Related]
13. NR4A1 deletion promotes pro-angiogenic polarization of macrophages derived from classical monocytes in a mouse model of neovascular age-related macular degeneration.
Droho S; Voigt AP; Sterling JK; Rajesh A; Chan KS; Cuda CM; Perlman H; Lavine JA
J Neuroinflammation; 2023 Oct; 20(1):238. PubMed ID: 37858232
[TBL] [Abstract][Full Text] [Related]
14. Affinity purification of human factor H on polypeptides derived from streptococcal m protein: enrichment of the Y402 variant.
Nilsson OR; Lannergård J; Morgan BP; Lindahl G; Gustafsson MC
PLoS One; 2013; 8(11):e81303. PubMed ID: 24278416
[TBL] [Abstract][Full Text] [Related]
15. mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells.
Merle DA; Provenzano F; Jarboui MA; Kilger E; Clark SJ; Deleidi M; Armento A; Ueffing M
Antioxidants (Basel); 2021 Dec; 10(12):. PubMed ID: 34943047
[TBL] [Abstract][Full Text] [Related]
16. PolySialic Acid Nanoparticles Actuate Complement-Factor-H-Mediated Inhibition of the Alternative Complement Pathway: A Safer Potential Therapy for Age-Related Macular Degeneration.
Peterson SL; Krishnan A; Patel D; Khanehzar A; Lad A; Shaughnessy J; Ram S; Callanan D; Kunimoto D; Genead MA; Tolentino MJ
Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675477
[TBL] [Abstract][Full Text] [Related]
17. Homodimeric Minimal Factor H:
Kamala O; Malik TH; Hallam TM; Cox TE; Yang Y; Vyas F; Luli S; Connelly C; Gibson B; Smith-Jackson K; Denton H; Pappworth IY; Huang L; Kavanagh D; Pickering MC; Marchbank KJ
Front Immunol; 2021; 12():752916. PubMed ID: 34956184
[TBL] [Abstract][Full Text] [Related]
18. Understanding AMD by analogy: systematic review of lipid-related common pathogenic mechanisms in AMD, AD, AS and GN.
Xu Q; Cao S; Rajapakse S; Matsubara JA
Lipids Health Dis; 2018 Jan; 17(1):3. PubMed ID: 29301530
[TBL] [Abstract][Full Text] [Related]
19. Murine Factor H Co-Produced in Yeast With Protein Disulfide Isomerase Ameliorated C3 Dysregulation in Factor H-Deficient Mice.
Kerr H; Herbert AP; Makou E; Abramczyk D; Malik TH; Lomax-Browne H; Yang Y; Pappworth IY; Denton H; Richards A; Marchbank KJ; Pickering MC; Barlow PN
Front Immunol; 2021; 12():681098. PubMed ID: 34054871
[TBL] [Abstract][Full Text] [Related]
20. Moss-produced human complement factor H with modified glycans has an extended half-life and improved biological activity.
Tschongov T; Konwar S; Busch A; Sievert C; Hartmann A; Noris M; Gastoldi S; Aiello S; Schaaf A; Panse J; Zipfel PF; Dabrowska-Schlepp P; Häffner K
Front Immunol; 2024; 15():1383123. PubMed ID: 38799460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
